FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:98 January 3, 2008 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

(Cancer Treatment and Research. Vol. 133.) Edited by Craig Meyers. 270 pp., illustrated. New York, Springer, 2007. $149. ISBN 978-0-387-46804-4.

Almost a quarter of a century has passed since the human immunodeficiency virus (HIV) was identified, and from the outset one of the keys to recognition of the epidemic was the identification of Kaposi's sarcoma as a defining condition of AIDS. The effect of this disease worldwide has been staggering, particularly in sub-Saharan Africa, but a by-product has been considerable insight into the role of the immune system in the neoplastic process and into the role of oncogenic viruses — particularly Kaposi's sarcoma–associated herpesvirus and Epstein–Barr virus (EBV), but also human papillomavirus, hepatitis B virus (HBV), and hepatitis C virus . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.